5 Multibagger Penny Stocks Of 2021 That Delivered Up To 1800% Return So Far

Penny stocks that are low on price cannot be betted upon by every investor class owing to the high risk and for the medium to long term now experts have been advising not to bet on penny stocks as these stocks with a low float carry a high risk and are subject to high manipulation.

Now even amid this take, along with other multibagger stock sectors, penny stocks too have performed immensely well in 2021. Note here the stocks considered have a market cap of over Rs. 500 crore.

1. JITF Infralogistics:

 The company commands a market cap of Rs. 575 crore and has recorded a surge of 3073 percent in the last one year. While YTD returns have also been phenomenal of over 1700 percent. The exorbitant price rise in the stock is being attributed to low liquidity in the stock. The other concern with the company is institutional holding in the company is by investors who were recently under the scanner owing to investment in Adani Group firms.

In the previous quarter ending June 2021, the company posted a net loss of Rs. 0.04 crore. The company's stock was locked in upper circuit from August to October 2021.

The company works in the area of water, wastewater and solid waste management, logistics and transportation equipment fabrication.

2. ANG Lifesciences:

The pharma company has returned a staggering 2896 percent return in the last 1-year, while YTD return have been over 1812%. After acquiring 2 formulation manufacturing facilities, the company's stock is on the run. Also, the company declared a bonus in the ratio of 1:1 which is also providing a stock the current fillip as the investors lap up stocks for which record date has been declared.

Incorporated in the year 2008, the company has its focus primarily on Dry Powder Injectables (SVP). ANG Lifescience is committed to Quality products and services that address the prevention , diagnosis and treatment of diseases, thus enhancing people's health and quality of life .

3. Orchid Pharma:

The pharma company over a 1-year period has risen 1890 percent and last quotes at a price of Rs. 413 per share on the NSE.

The was relisted in 2020 at a price of Rs. 18 and since then till April of this year gave an over 14000 percent return. Limited stock or free float is the main reason spurring the stock price of Orchid.

Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd. (Orchid) is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.
Orchid Pharma last commands an market cap of Rs. 1685 crore.The stock's 52-week high price is Rs. 2654.

4. 3i Infotech:

The computer software firm was relisted and since then has been in high demand after the company's debt restructuring plan. As a result of the new plan, the company's capital base has been brought down. The stock is expected to see further upside. The company is now a debt free enterprise.
Over the year gone by, shares of the company have gained 1,468%.

5. Authum Investment

Authum Investment & Infrastructure is a registered NBFC, carrying on the business of investment in shares & securities and also, financing activities. The company has been in news after it came out as the successful bidder for the acquisition of Reliance Commercial Finance (RCF) and Reliance Home Finance. Authum will pay around Rs 22 bn for RCF and close to Rs 29 bn for Reliance Home Finance.

Stocks	YTD return	1 year return	Sector
ANG Lifesciences	1812%	2896%	Pharma
Authum Investment	714%	940%	NBFC
JITF Infralogistics	>1700%	3073%	Diversified
Orchid Pharma		1890%	Pharma
3i Infotech	715.5%	1683%	Software

 

Disclaimer:

The story above just highlights the mind boggling returns these penny stocks managed to gave, nonetheless it is not a recommendation to buy in these shares as these stocks in particular are highly risky and past returns are no metric to decide on an investment.

GoodReturns.in